Abstract
Prolonged use of β 2-adrenoceptor agonists has been associated with asthma exacerbation. Recently, phospholipase C-β1 (PLC-β1) induction in airway smooth muscle was proposed to underlie this phenomenon. We aimed to evaluate this mechanism in primary human airway smooth muscle cells. Stimulation of cells (1 μM isoprenaline or salbutamol for 2–48 h or 10 − 9 –10 − 4 M for 24 h) had no effect on PLC-β1 gene expression. 1 μM β 2-adrenoceptor agonist treatment for 24 h did not alter sodium fluoride Inositol Phosphate (IP) responses, however augmented histamine IP responses ( P < 0.05). Therefore, β 2-adrenoceptor agonists can augment spasmogen responses in airway smooth muscle but not via a G-protein/PLC-β1 mediated mechanism.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
